2,590
Views
0
CrossRef citations to date
0
Altmetric
HPV – Research Article

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer

, , , , , , , , & ORCID Icon show all
Article: 2109892 | Received 29 Dec 2021, Accepted 02 Aug 2022, Published online: 07 Sep 2022

References

  • Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013 Mar;40(3):1–8. doi:10.1097/OLQ.0b013e318286bb53.
  • Adjei Boakye E, Buchanan P, Hinyard L, Osazuwa-Peters N, Schootman M, Piccirillo JF. Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 Aug 1;144(8);727–737. doi:10.1001/jamaoto.2018.0993.
  • Adjei Boakye E, Grubb L, Peterson CE, Osazuwa-Peters N, Grabosch S, Ladage HD, Huh WK. Risk of second primary cancers among survivors of gynecological cancers. Gynecol Oncol. 2020 Sep;158(3):719–726. doi:10.1016/j.ygyno.2020.06.492.
  • Wang M, Sharma A, Osazuwa-Peters N, Simpson MC, Schootman M, Piccirillo JF, Huh WK, Adjei Boakye E. Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers. Cancer Epidemiol. 2020;64:101649. doi:10.1016/j.canep.2019.101649.
  • Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(S10):3036–3046. doi:10.1002/cncr.23764.
  • Osazuwa-Peters N, Graboyes EM, Khariwala SS. Expanding indications for the human papillomavirus vaccine: one small step for the prevention of head and neck cancer, but one giant leap remains. JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12);1099–1101. doi:10.1001/jamaoto.2020.4068.
  • Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014 May;50(5):380–386. doi:10.1016/j.oraloncology.2013.12.019.
  • Osazuwa-Peters N, Simpson MC, Massa ST, Adjei Boakye E, Antisdel JL, Varvares MA. 40-Year incidence trends for oropharyngeal squamous cell carcinoma in the United States. Oral Oncol. 2017 Nov 1;74(Supplement C):90–97. doi:10.1016/j.oraloncology.2017.09.015.
  • Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, Kahle L, Gillison ML. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2018 Jan 20;36(3):262–267. doi:10.1200/jco.2017.75.0141.
  • Osazuwa-Peters N, Rohde RL, Boakye EA. HPV vaccination is safe-you don’t have to whisper it. JAMA Network Open. 2021 Sep 1;4(9):e2125124. doi:10.1001/jamanetworkopen.2021.25124.
  • Sonawane K, Lin YY, Damgacioglu H, et al. Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Network Open. 2021 Sep 1;4(9):e2124502. doi:10.1001/jamanetworkopen.2021.24502.
  • Adjei Boakye E, Lew D, Muthukrishnan M, Tobo BB, Rohde RL, Varvares MA, Osazuwa-Peters N. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18–26 year olds in the United States. Human Vaccines Immunotherapeutics. 2018;14(8):2016–2024. doi:10.1080/21645515.2018.1467203.
  • Adjei Boakye E, Zeng W, Governor S, Nagendra S, Tobo BB, Simpson MC, Osazuwa-Peters N. Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18–34 years. Prev Med Rep. 2019 Dec;16:101010. doi:10.1016/j.pmedr.2019.101010.
  • Barnard M, George P, Perryman ML, Wolff LA, De Groot AS. Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: implications from the precaution adoption process model. PloS One. 2017;12(8):e0182266. doi:10.1371/journal.pone.0182266.
  • Thompson EL, Vamos CA, Vázquez-Otero C, Logan R, Griner S, Daley EM. Trends and predictors of HPV vaccination among U.S. College women and men. Prev Med. 2016 May;86:92–98. doi:10.1016/j.ypmed.2016.02.003.
  • Dempsey AF, Pyrzanowski J, Campagna EJ, Lockhart S, O’Leary ST. Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention. Vaccine. 2019 Feb 28;37(10):1307–1312. doi:10.1016/j.vaccine.2019.01.051.
  • Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018 May 7;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016.
  • Mohammed KA, Geneus CJ, Osazuwa-Peters N, Adjei Boakye E, Tobo BB, Burroughs TE. Disparities in provider recommendation of human papillomavirus vaccination for U.S. adolescents. J Adolesc Health. 2016 Nov;59(5):592–598. doi:10.1016/j.jadohealth.2016.06.005.
  • Schnaith AM, Evans EM, Vogt C, Tinsay AM, Schmidt TE, Tessier KM, Erickson BK. An innovative medical school curriculum to address human papillomavirus vaccine hesitancy. Vaccine. 2018 Jun 18;36(26):3830–3835. doi:10.1016/j.vaccine.2018.05.014.
  • Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician’s recommendation. Vaccine. 2011 Jan 29;29(5):890–895. doi:10.1016/j.vaccine.2009.12.063.
  • Oshman LD, Davis AM. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). JAMA. 2020 Feb 4;323(5):468–469. doi:10.1001/jama.2019.18411.
  • Burger EA, Kim JJ, Sy S, Castle PE. Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin Infect Dis. 2017 Sep 15;65(6):893–899. doi:10.1093/cid/cix475.
  • Chen J, Gopala K, Akarsh PK, Struyf F, Rosillon D. Prevalence and incidence of human papillomavirus (HPV) infection before and after pregnancy: pooled analysis of the control arms of efficacy trials of HPV-16/18 AS04-adjuvanted vaccine. Open Forum Infect Dis. 2019 Dec;6(12):ofz486. doi:10.1093/ofid/ofz486.
  • Habel MA, Leichliter JS, Dittus PJ, Spicknall IH, Aral SO. Heterosexual anal and oral sex in adolescents and adults in the United States, 2011-2015. Sex Transm Dis. 2018 Dec;45(12):775–782. doi:10.1097/olq.0000000000000889.
  • Afonso NM, Kavanagh MJ, Swanberg SM, Schulte JM, Wunderlich T, Lucia VC. Will they lead by example? Assessment of vaccination rates and attitudes to human papilloma virus in millennial medical students. BMC Public Health. 2017 Jan 6;17(1):35. doi:10.1186/s12889-016-3969-x.
  • Daniel CL, McLendon L, Green CL, Anderson KJ, Pierce JY, Perkins A, Beasley M. HPV and HPV vaccination knowledge and attitudes among medical students in Alabama. J Cancer Educ. 2021 Feb;36(1):168–177. doi:10.1007/s13187-019-01613-3.
  • Tung WC, Lu M, Qiu X, Ervin S. Human papillomavirus knowledge, attitudes, and vaccination among Chinese college students in the United States. Vaccine. 2019 May 27;37(24):3199–3204. doi:10.1016/j.vaccine.2019.04.084.
  • Franca MC, Boyer VE, Gerend MA, Lee M, Whittington KD, McKinney SL, Collins SK, McKinnies RC, Adjei Boakye E. College students’ awareness of the link between human papillomavirus (HPV) and HPV-associated cancers. J Cancer Educ. 2022 Apr 22. doi:10.1007/s13187-022-02172-w.
  • Laitman BM, Ronner L, Oliver K, Genden E. US medical trainees’ knowledge of human papilloma virus and head and neck cancer. Otolaryngol Head Neck Surg. 2020 Jan;162(1):56–59. doi:10.1177/0194599819886117.
  • Evans L, Matley E, Oberbillig M, Margetts E, Darrow L. HPV knowledge and attitudes among medical and professional students at a Nevada university: a focus on oropharyngeal cancer and mandating the vaccine. J Cancer Educ. 2020 Aug;35(4):774–781. doi:10.1007/s13187-019-01529-y.
  • Cruz GD, Le Geros RZ, Ostroff JS, Hay JL, Kenigsberg H, Franklin DM. Oral cancer knowledge, risk factors and characteristics of subjects in a large oral cancer screening program. J Am Dent Assoc. 2002 Aug;133(8):1064–71; quiz 1094. doi:10.14219/jada.archive.2002.0330.
  • Lambert EC. College students’ knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001 May-Jun;14(3):178–183.
  • Wilson AR, Hashibe M, Bodson J, Gren LH, Taylor BA, Greenwood J, Jackson BR, She R, Egger MJ, Kepka D, et al. Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: An observational study. BMC Womens Health. 2016 Jul 22;16(1):41. doi:10.1186/s12905-016-0323-5.
  • Osazuwa-Peters N, Tutlam NT. Knowledge and risk perception of oral cavity and oropharyngeal cancer among non-medical university students. J Otolaryngol - Head Neck Surg = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale. 2016 Jan 28;45(1):5. doi:10.1186/s40463-016-0120-z.
  • Laitman BM, Oliver K, Genden E. Medical student knowledge of human papillomavirus–positive head and neck cancer. JAMA Otolaryngology–Head Neck Surg. 2018;144(4):380–382. doi:10.1001/jamaoto.2017.3089.
  • U.S. Department of Health and Human Services. Healthy people 2020 topics & objectives: Immunization and infectious diseases. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives
  • Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Human Vaccines Immunotherapeutics. 2017 Nov 2;13(11):2713–2722. doi:10.1080/21645515.2017.1363133.
  • Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ, Schootman M. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med. 2017 Jun;99:299–304. doi:10.1016/j.ypmed.2017.03.014.
  • Osazuwa-Peters N, Hu A, Rohde RL, Tobo BB, Geneus CJ, Mohammed KA, Adjei Boakye E. Sociodemographic predictors of the human papillomavirus (HPV) and HPV vaccine knowledge and awareness among Americans who use the internet as their primary source of health information. J Consum Health Internet. 2018;22(3):199–216. doi:10.1080/15398285.2018.1509258.
  • Daley EM, Vamos CA, Zimet GD, Rosberger Z, Thompson EL, Merrell L. The feminization of HPV: reversing gender biases in US human papillomavirus vaccine policy. Am J Public Health. 2016 Jun;106(6):983–984. doi:10.2105/ajph.2016.303122.
  • Lindley MC, Jeyarajah J, Yankey D, Curtis CR, Markowitz LE, Stokley S. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls. Human Vaccines Immunotherapeutics. 2016 Jun 2;12(6):1519–1527. doi:10.1080/21645515.2016.1157673.
  • Adjei Boakye E, Babatunde OA, Wang M, Osazuwa-Peters N, Jenkins W, Lee M, Kim M. Geographic variation in human papillomavirus vaccination initiation and completion among young adults in the U.S. Am J Prev Med. 2021 Mar;60(3):387–396. doi:10.1016/j.amepre.2020.09.005.
  • Osazuwa-Peters N, Adjei Boakye E, Chen BY, Clancy J, Vallot PL, Su JL, Beck GE, Varvares MA. Sociodemographic factors associated with knowledge and risk perception of human papillomavirus and human papillomavirus–associated oropharyngeal squamous cell carcinoma among a predominantly black population. JAMA Otolaryngol–Head Neck Surg. 2017 Feb 1;143(2):117–124. doi:10.1001/jamaoto.2016.2784.
  • Osazuwa-Peters N, Adjei Boakye E, Hussaini AS, et al. Characteristics and predictors of oral cancer knowledge in a predominantly African American community. PloS One. 2017;12(5):e0177787. doi:10.1371/journal.pone.0177787.
  • Daniel-Ulloa J, Gilbert PA, Parker EA. Human papillomavirus vaccination in the UNIted States: uneven uptake by gender, race/ethnicity, and sexual orientation. Am J Public Health. 2016 Apr;106(4):746–747. doi:10.2105/ajph.2015.303039.
  • Burdette AM, Webb NS, Hill TD, Jokinen-Gordon H. Race-Specific trends in HPV vaccinations and provider recommendations: Persistent disparities or social progress? Public Health. 2017 Jan;142:167–176. doi:10.1016/j.puhe.2016.07.009.
  • Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey. Am J Public Health. 2013 Jan;103(1):164–169. doi:10.2105/ajph.2011.300600.
  • Saha S, Komaromy M, Koepsell TD, Bindman AB. Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med. 1999;159(9):997–1004. doi:10.1001/archinte.159.9.997.
  • Shen MJ, Peterson EB, Costas-Muñiz R, Hernandez MH, Jewell ST, Matsoukas K, Bylund CL. The effects of race and racial concordance on patient-physician communication: a systematic review of the literature. J Racial Ethnic Health Disparities. 2018 Feb;5(1):117–140. doi:10.1007/s40615-017-0350-4.
  • Zhang D, Li G, Mu L, Thapa J, Li Y, Chen Z, Shi L, Su D, Son H, Pagan JA, et al. Trends in medical school application and matriculation rates across the United States from 2001 to 2015: implications for health disparities. Acad Med. 2021 Jun 1;96(6):885–893. doi:10.1097/acm.0000000000004033.
  • Osazuwa-Peters N, Massa ST, Simpson MC, Adjei Boakye E, Varvares MA. Survival of human papillomavirus-associated cancers: filling in the gaps. Cancer. 2018 Jan 1;124(1):18–20. doi:10.1002/cncr.30945.